Results 61 to 70 of about 13,826 (180)

Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis

Frontiers in Cellular and Infection Microbiology, 2018
Francisella tularensis is the causative agent of tularemia and a Tier I bioterrorism agent. In the 1900s, several vaccines were developed against tularemia including the killed “Foshay” vaccine, subunit vaccines comprising F.
Qingmei Jia, Marcus A. Horwitz
doaj   +1 more source

Bioterrorism and the People: How to Vaccinate a City against Panic [PDF]

, 2002
Thomas A. Glass, Monica Schoch‐Spana
openalex   +1 more source

Use of Automated Ambulatory-Care Encounter Records for Detection of Acute Illness Clusters, Including Potential Bioterrorism Events

Emerging Infectious Diseases, 2002
The advent of domestic bioterrorism has emphasized the need for enhanced detection of clusters of acute illness. We describe a monitoring system operational in eastern Massachusetts, based on diagnoses obtained from electronic records of ambulatory-care ...
Ross Lazarus, Ken Kleinman, Inna Dashevsky, Courtney Adams, Patricia Kludt, Alfred DeMaria, Richard Platt   +6 more
doaj   +1 more source

Bioterrorism [PDF]

, 2010
Luciana L. Borio, Donald A. Henderson, Noreen A. Hynes   +2 more
  +5 more sources

Assessment of community healthcare providers ability and willingness to respond to emergencies resulting from bioterrorist attacks

Journal of Emergencies, Trauma and Shock, 2010
Introduction: Previous findings have demonstrated that preparedness and planning within the public health system are inadequately developed to respond to an act of biological or chemical terrorism.
Crane Jeffery, McCluskey James, Johnson Giffe, Harbison Raymond   +3 more
doaj  

Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

Emerging Infectious Diseases, 2002
The potential threat of biological warfare with a specific agent is proportional to the susceptibility of the population to that agent. Preventing disease after exposure to a biological agent is partially a function of the immunity of the exposed ...
Arturo Casadevall
doaj   +1 more source

Emergency Use Authorization (EUA) to Enable Use of Needed Products in Civilian and Military Emergencies, United States

Emerging Infectious Diseases, 2007
The US Emergency Use Authorization (EUA) is a critical new tool for medical and public health communities and is applicable for both civilian and military use.
Stuart L. Nightingale, Joanna M. Prasher, Stewart Simonson   +2 more
doaj   +1 more source

Smallpox and bioterrorism

Bulletin of the World Health Organization, 2003
Smallpox was declared to be eradicated on 8 May 1980, during the Thirty-third World Health Assembly. However, concerns about the possible use of the virus as a weapon of bioterrorism have increased in recent years.
Pennington Hugh
doaj  

Laboratory Exposures to Brucellae and Implications for Bioterrorism

Emerging Infectious Diseases, 2005
Brucellae are class 3 organisms and potential agents of bioterrorism. Because of effective public health measures, brucellosis has become a rare disease in industrialized countries, and clinical microbiology laboratories are frequently unfamiliar with ...
Pablo Yagupsky, Ellen Jo Baron
doaj   +1 more source

CDC Teleconference on Bioterrorism and Epidemiology [PDF]

, 2001
Gina Pugliese, Martin S. Favero
openalex   +1 more source